Research output per year
Research output per year
Personal profile
Research interests
Rheumatology (ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis), rare diseases, genetics
Education/Academic qualification
3.2 Clinical medicine, Expert, Latvian Council of Science
2 Dec 2021 → 1 Dec 2024
Field of Science
- 3.2 Clinical medicine
Keywords
- ankylosing spondylitis
- psoriatic arthritis
- rheumatoid arthritis
- rare diseases
- genetics
- systemic lupus erythematosus
- gout
Fingerprint
Dive into the research topics where Jūlija Zepa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
12 biežāk uzdotie jautājumi par psoriāzi un psoriātisku artrītu dermatologa un reimatologa praksē
Sidhoma, E. & Zepa, J., Apr 2022, Latvijas Ārsts, 4, p. 27-30.Research output: Contribution to specialist publication › Specialist article
-
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry
Machado, P. M., Lawson-Tovey, S., Strangfeld, A., Mateus, E. F., Hyrich, K. L., Gossec, L., Carmona, L., Rodrigues, A., Raffeiner, B., Duarte, C., Hachulla, E., Veillard, E., Strakova, E., Burmester, G. R., Yardımcı, G. K., Gomez-Puerta, J. A., Zepa, J., Kearsley-Fleet, L., Trefond, L., Cunha, M. & 11 others, , May 2022, In: Annals of the Rheumatic Diseases. 81, 5, 695-709.Research output: Contribution to journal › Article › peer-review
Open Access -
SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: Results from the COVID-19 Global Rheumatology Alliance provider registry
Liew, J., Gianfrancesco, M., Harrison, C., Izadi, Z., Rush, S., Lawson-Tovey, S., Jacobsohn, L., Ja, C., Hyrich, K. L., Gossec, L., Strangfeld, A., Carmona, L., Schafer, M., Frazao-Mateus, E., Bulina, I., Stafford, F., Tufan, A., Graver, C., Yardlmcl, G. K., Zepa, J. & 25 others, , 6 Apr 2022, In: RMD Open. 8, 1, e002187.Research output: Contribution to journal › Article › peer-review
Open Access -
Association between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death among Patients with Immune-Mediated Inflammatory Disease and COVID-19
Izadi, Z., Brenner, E. J., Psoriasis Patient Registry Outcome, Secure Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD), COVID-19 Global Rheumatology Alliance, Zepa, J. & Buliņa, I., Oct 2021, In: JAMA network open. 4, 10, e2129639.Research output: Contribution to journal › Article › peer-review
Open AccessFile11 Citations (Scopus) -
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
Sparks, J. A., COVID-19 Global Rheumatology Alliance, Zepa, J. & Buliņa, I., 1 Sep 2021, In: Annals of the Rheumatic Diseases. 80, 9, p. 1137-1146 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile44 Citations (Scopus)1 Downloads (Pure)
-
The profile of patients consulted by rheumatologists in the largest outpatient department in Latvia during the first month of the COVID-19 pandemic
Jūlija Zepa (Speaker)
24 Mar 2021Activity: Talk or presentation types › Poster presentation
-
Latvian Society of Adult Rheumatology (External organisation)
Jūlija Zepa (Member)
2020 → …Activity: Membership types › Membership of NGOs
Press / Media
-
-
Sadzīvot ar reimatoīdo artrītu: pacientu izglītošana ir viena no veiksmes atslēgām
21/10/20
1 item of Media coverage
Press/Media